Powered by

-Faron Pharmaceuticals Oy - Subscription and Open Offer

Aug 06, 2019 - ENP Newswire

TURKU - Faron Pharmaceuticals Oy ('Faron') (AIM: FARN), the clinical stage biopharmaceutical company, is pleased to announce a subscription of new ordinary shares in the capital of the Company (the 'Subscription') to raise proceeds of approximately EUR 1.12 million (GBP1.00 million) before expenses.

The Subscription comprises the issue of 941,840 new ordinary shares (the 'Subscription Shares') at the issue price of of EUR1.19 per share ('Euro Issue Price').

In addition, to provide Qu...